Related Experiment Video
Updated: Aug 5, 2026

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
Bibliometric Trends in Inflammasome‑Driven Pyroptosis and Cardiovascular Disease
Yupei Tan1, Wei Wang1, Rui Qiang1
1Beijing Hospital of Traditional Chinese Medicine, Shunyi Hospital, Beijing, People's Republic of China.
Insights
This study maps inflammasome-driven pyroptosis research in cardiovascular disease (CVD). NLRP3 inflammasome is central, with emerging focus on pyroptosis and ferroptosis crosstalk for future clinical trials.
Area of Science:
- Cardiovascular Research
- Immunology
- Cell Death Mechanisms
Background:
- Pyroptosis, an inflammatory programmed cell death, is crucial in cardiovascular diseases (CVDs) like hypertension, atherosclerosis, and heart failure.
- Inflammasome activation drives pyroptosis, a rapidly growing research area within CVD.
- No prior bibliometric analysis has comprehensively synthesized inflammasome-driven pyroptosis research in CVD.
Purpose of the Study:
- To conduct the first bibliometric analysis of inflammasome-driven pyroptosis research in cardiovascular disease.
- To systematically map the evolution, trends, and key areas of this research field.
- To identify emerging hotspots and future research directions.
Main Methods:
- Bibliometric and visual analyses were performed on 4,511 documents (1998-2025) from the Web of Science Core Collection.
- CiteSpace and VOSviewer were utilized to analyze publication trends, country/region, institutions, authors, journals, and keywords.
- Keyword co-occurrence analysis identified research clusters and emerging trends.
Main Results:
- China leads in publications (50.1%), while the US has the highest h-index (147). Harvard University is a leading institution.
- The NLRP3 inflammasome is the most frequently studied and cited topic.
- Emerging research frontiers include the interplay between pyroptosis and ferroptosis, with recent bursts in 2024-2025.
Conclusions:
- NLRP3 inflammasome is the core focus in inflammasome-driven pyroptosis research in CVD.
- Research is shifting from basic mechanisms to translational applications.
- Future research should explore pyroptosis-ferroptosis crosstalk and patient stratification for clinical trials.
Background And Purpose:
This bibliometric study provides the first comprehensive synthesis of inflammasome‑driven pyroptosis research in cardiovascular disease (CVD), systematically mapping its evolution. Pyroptosis, an inflammatory form of programmed cell death triggered by inflammasome activation, plays a critical role in various CVDs, including hypertension, ischemia‑reperfusion injury (I/R injury), atherosclerosis, and heart failure (HF). Despite rapid growth of the literature, no bibliometric analysis has specifically focused on this area.
Patients And Methods:
Data were retrieved from the Web of Science Core Collection (1998-April 27, 2025). Bibliometric and visual analyses were performed using CiteSpace and VOSviewer to examine publication trends, country/region, funding agency, institution, author, journal, subject category, co‑cited reference, keyword co‑occurrence, and emerging hotspots.
Results:
A total of 4,511 documents (2,918 original articles and 1,593 reviews) were included. China contributed 2,259 publications (50.1% of total) with 56,326 citations; the United States contributed 1,022 publications (22.7%) with 79,057 citations and the highest country‑level h‑index (147); and Italy ranked third with 290 publications (6.4%). Harvard University and its affiliated institutions led in both publication quantity and impact (h‑index, citations per article). Keyword co‑occurrence identified four clusters: pyroptosis mechanisms, NLRP3 inflammasome, signaling pathways, and CVDs. Recent bursts (2024‑2025) highlight "pyroptosis" and "ferroptosis" as emerging frontiers.
Conclusion:
This bibliometric study identifies NLRP3 as the central research focus in inflammasome‑driven pyroptosis research, with the strongest citation burst. The findings reveal a shift from basic mechanistic studies toward translational research, highlighting emerging priorities such as the crosstalk between pyroptosis and ferroptosis and the need for patient stratification in future clinical trials.
Related Concept Videos
The JAK-STAT Signaling Pathway
Inflammation
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Myocarditis I: Introduction

